Kaos Capital Ltd - 25 Nov 2025 SCHEDULE 13D Report for PSYENCE BIOMEDICAL LTD. Common Stock, without par value (PBM)

Filing Manager
Kaos Capital Ltd
Reporting Manager
KAOS Capital Ltd.
Security
PSYENCE BIOMEDICAL LTD. Common Stock, without par value
Symbol
PBM
Shares outstanding
1,871,652 shares
Disclosed Ownership
313,876 shares
Ownership
17%
Form type
SCHEDULE 13D
Filing time
10 Dec 2025, 18:09:10 UTC
Date of event
25 Nov 2025
Next filing
13 Jan 2026
SEC
View on sec.gov

Quoteable Key Fact

"Kaos Capital Ltd disclosed 17% ownership in PSYENCE BIOMEDICAL LTD. Common Stock, without par value (PBM) on 25 Nov 2025."

Quick Takeaways

  • Kaos Capital Ltd filed SCHEDULE 13D for PSYENCE BIOMEDICAL LTD. Common Stock, without par value (PBM).
  • Disclosed ownership: 17%.
  • Date of event: 25 Nov 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Dec 2025, 18:09.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
KAOS Capital Ltd. 17% 313,876 0 313,876 /s/ Adam Arviv Adam Arviv / Chief Executive Officer 0002100448
Adam Arviv 17% 313,876 0 313,876 /s/ Adam Arviv Adam Arviv, Individually 0002100451